Cargando…

A computational approach based on the colored Petri net formalism for studying multiple sclerosis

BACKGROUND: Multiple Sclerosis (MS) is an immune-mediated inflammatory disease of the Central Nervous System (CNS) which damages the myelin sheath enveloping nerve cells thus causing severe physical disability in patients. Relapsing Remitting Multiple Sclerosis (RRMS) is one of the most common form...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernice, Simone, Pennisi, Marzio, Romano, Greta, Maglione, Alessandro, Cutrupi, Santina, Pappalardo, Francesco, Balbo, Gianfranco, Beccuti, Marco, Cordero, Francesca, Calogero, Raffaele A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904991/
https://www.ncbi.nlm.nih.gov/pubmed/31822261
http://dx.doi.org/10.1186/s12859-019-3196-4
_version_ 1783478088751906816
author Pernice, Simone
Pennisi, Marzio
Romano, Greta
Maglione, Alessandro
Cutrupi, Santina
Pappalardo, Francesco
Balbo, Gianfranco
Beccuti, Marco
Cordero, Francesca
Calogero, Raffaele A.
author_facet Pernice, Simone
Pennisi, Marzio
Romano, Greta
Maglione, Alessandro
Cutrupi, Santina
Pappalardo, Francesco
Balbo, Gianfranco
Beccuti, Marco
Cordero, Francesca
Calogero, Raffaele A.
author_sort Pernice, Simone
collection PubMed
description BACKGROUND: Multiple Sclerosis (MS) is an immune-mediated inflammatory disease of the Central Nervous System (CNS) which damages the myelin sheath enveloping nerve cells thus causing severe physical disability in patients. Relapsing Remitting Multiple Sclerosis (RRMS) is one of the most common form of MS in adults and is characterized by a series of neurologic symptoms, followed by periods of remission. Recently, many treatments were proposed and studied to contrast the RRMS progression. Among these drugs, daclizumab (commercial name Zinbryta), an antibody tailored against the Interleukin-2 receptor of T cells, exhibited promising results, but its efficacy was accompanied by an increased frequency of serious adverse events. Manifested side effects consisted of infections, encephalitis, and liver damages. Therefore daclizumab has been withdrawn from the market worldwide. Another interesting case of RRMS regards its progression in pregnant women where a smaller incidence of relapses until the delivery has been observed. RESULTS: In this paper we propose a new methodology for studying RRMS, which we implemented in GreatSPN, a state-of-the-art open-source suite for modelling and analyzing complex systems through the Petri Net (PN) formalism. This methodology exploits: (a) an extended Colored PN formalism to provide a compact graphical description of the system and to automatically derive a set of ODEs encoding the system dynamics and (b) the Latin Hypercube Sampling with PRCC index to calibrate ODE parameters for reproducing the real behaviours in healthy and MS subjects.To show the effectiveness of such methodology a model of RRMS has been constructed and studied. Two different scenarios of RRMS were thus considered. In the former scenario the effect of the daclizumab administration is investigated, while in the latter one RRMS was studied in pregnant women. CONCLUSIONS: We propose a new computational methodology to study RRMS disease. Moreover, we show that model generated and calibrated according to this methodology is able to reproduce the expected behaviours.
format Online
Article
Text
id pubmed-6904991
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69049912019-12-11 A computational approach based on the colored Petri net formalism for studying multiple sclerosis Pernice, Simone Pennisi, Marzio Romano, Greta Maglione, Alessandro Cutrupi, Santina Pappalardo, Francesco Balbo, Gianfranco Beccuti, Marco Cordero, Francesca Calogero, Raffaele A. BMC Bioinformatics Research BACKGROUND: Multiple Sclerosis (MS) is an immune-mediated inflammatory disease of the Central Nervous System (CNS) which damages the myelin sheath enveloping nerve cells thus causing severe physical disability in patients. Relapsing Remitting Multiple Sclerosis (RRMS) is one of the most common form of MS in adults and is characterized by a series of neurologic symptoms, followed by periods of remission. Recently, many treatments were proposed and studied to contrast the RRMS progression. Among these drugs, daclizumab (commercial name Zinbryta), an antibody tailored against the Interleukin-2 receptor of T cells, exhibited promising results, but its efficacy was accompanied by an increased frequency of serious adverse events. Manifested side effects consisted of infections, encephalitis, and liver damages. Therefore daclizumab has been withdrawn from the market worldwide. Another interesting case of RRMS regards its progression in pregnant women where a smaller incidence of relapses until the delivery has been observed. RESULTS: In this paper we propose a new methodology for studying RRMS, which we implemented in GreatSPN, a state-of-the-art open-source suite for modelling and analyzing complex systems through the Petri Net (PN) formalism. This methodology exploits: (a) an extended Colored PN formalism to provide a compact graphical description of the system and to automatically derive a set of ODEs encoding the system dynamics and (b) the Latin Hypercube Sampling with PRCC index to calibrate ODE parameters for reproducing the real behaviours in healthy and MS subjects.To show the effectiveness of such methodology a model of RRMS has been constructed and studied. Two different scenarios of RRMS were thus considered. In the former scenario the effect of the daclizumab administration is investigated, while in the latter one RRMS was studied in pregnant women. CONCLUSIONS: We propose a new computational methodology to study RRMS disease. Moreover, we show that model generated and calibrated according to this methodology is able to reproduce the expected behaviours. BioMed Central 2019-12-10 /pmc/articles/PMC6904991/ /pubmed/31822261 http://dx.doi.org/10.1186/s12859-019-3196-4 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pernice, Simone
Pennisi, Marzio
Romano, Greta
Maglione, Alessandro
Cutrupi, Santina
Pappalardo, Francesco
Balbo, Gianfranco
Beccuti, Marco
Cordero, Francesca
Calogero, Raffaele A.
A computational approach based on the colored Petri net formalism for studying multiple sclerosis
title A computational approach based on the colored Petri net formalism for studying multiple sclerosis
title_full A computational approach based on the colored Petri net formalism for studying multiple sclerosis
title_fullStr A computational approach based on the colored Petri net formalism for studying multiple sclerosis
title_full_unstemmed A computational approach based on the colored Petri net formalism for studying multiple sclerosis
title_short A computational approach based on the colored Petri net formalism for studying multiple sclerosis
title_sort computational approach based on the colored petri net formalism for studying multiple sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904991/
https://www.ncbi.nlm.nih.gov/pubmed/31822261
http://dx.doi.org/10.1186/s12859-019-3196-4
work_keys_str_mv AT pernicesimone acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT pennisimarzio acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT romanogreta acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT maglionealessandro acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT cutrupisantina acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT pappalardofrancesco acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT balbogianfranco acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT beccutimarco acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT corderofrancesca acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT calogeroraffaelea acomputationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT pernicesimone computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT pennisimarzio computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT romanogreta computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT maglionealessandro computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT cutrupisantina computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT pappalardofrancesco computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT balbogianfranco computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT beccutimarco computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT corderofrancesca computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis
AT calogeroraffaelea computationalapproachbasedonthecoloredpetrinetformalismforstudyingmultiplesclerosis